Similar articles

• Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats.

  Kemp JW, Tannhauser M, Swinyard EA. Kemp JW, et al. Arch Int Pharmacodyn Ther. 1971 Sep;193(1):37-47. Arch Int Pharmacodyn Ther. 1971. PMID: 5111324 No abstract available.
• Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.

  Stavchansky SA, Lubawy WC, Kostenbauder HB. Stavchansky SA, et al. Life Sci. 1974 Apr 16;14(8):1535-9. doi: 10.1016/0024-3205(74)90164-7. Life Sci. 1974. PMID: 4829543 No abstract available.
• Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.

  Stitzel RE, Anders MW, Mannering GJ. Stitzel RE, et al. Mol Pharmacol. 1966 Jul;2(4):335-40. Mol Pharmacol. 1966. PMID: 5968073 No abstract available.
• Diethylnitrosamine-induced changes in mouse liver morphology and function.

  Gans JH. Gans JH. Proc Soc Exp Biol Med. 1976 Oct;153(1):116-20. doi: 10.3181/00379727-153-39492. Proc Soc Exp Biol Med. 1976. PMID: 995932 No abstract available.
• Effects of urea on hexobarbital and antipyrine disposition in rats.

  Valentovic M, Bachmann K. Valentovic M, et al. Pharmacology. 1980;21(3):167-74. doi: 10.1159/000137429. Pharmacology. 1980. PMID: 7413718